NCT05975346

Brief Summary

Sore throat includes specific symptoms such as dysphagia, dysphonia, hoarseness, continuous throat pain, and pharyngeal dryness. Patients rated postoperative sore throat (POST) as the eighth most undesirable outcome in the postoperative period POST has a reported incidence of up to 62% following general anesthesia (GA). The incidence of POST is more common in GA with tracheal intubation than in GA with the supraglottic airway Ketamine is an N-methyl-D-aspartate (NMDA) receptor antagonist and has been used as a gargle for reducing the incidence and severity of POST due to its anti-nociceptive and anti-inflammatory effects

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 27, 2023

Completed
5 days until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 3, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

August 3, 2023

Status Verified

July 1, 2023

Enrollment Period

5 months

First QC Date

July 27, 2023

Last Update Submit

July 27, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • the incidence and severity of POST

    the study is to measure the incidence and severity of POST at immediate recovery (0 h), 2, 4, 6, 8, 12 and 24 h post-operatively. in adult patients undergoing surgery of a duration less than 2h.

    at immediate recovery (0 h), 2, 4, 6, 8, 12 and 24 h post-operatively.

Secondary Outcomes (1)

  • evaluation of side effects including nausea, vomiting, cough, and dry mouth in both groups.

    at immediate recovery (0 h), 2, 4, 6, 8, 12 and 24 h post-operatively.

Study Arms (2)

(K) Ketamine group

40 patients will receive ketamine 50mg (1.0 ml with 4.0 ml of the saline) nebulization

Drug: Ketamine

(S) Saline group

40 patients will receive saline nebulization (5ml).

Other: saline nebulization

Interventions

description

(K) Ketamine group

description

(S) Saline group

Eligibility Criteria

Age16 Years - 60 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

1. Age 16-60 years. 2. Of both sex. 3. American Society of Anesthesiologists Physical Status (ASA PS) I-II. 4. Undergoing general anesthesia with endotracheal intubation with surgery duration less than two hours.

You may qualify if:

  • Age 16-60 years.
  • Of both sex.
  • American Society of Anesthesiologists Physical Status (ASA PS) I-II.
  • Undergoing general anesthesia with endotracheal intubation with surgery duration less than two hours.

You may not qualify if:

  • a- History of chronic obstructive History of sore throat or upper respiratory tract infection.
  • b- Intraoral and intrapharyngeal surgery. c- airway disease or Asthma. d- Mallampati grade more than II. e- Known allergic to study drug. f- More than one attempt is required for intubation. g- Hypertensive patients. h- Epileptic patients. i- cerebral palsy or any neurological disorders. j- Psychiatry patients. k- Cardiac patients. l- Perioperative use of anti-inflammatory drugs (Non-steroidal anti-inflammatory drug or steroids).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Cairns A, Battleday FM, Velikova G, Brunelli A, Bell H, Favo J, Patella M, Lindner O, Pompili C. General patient satisfaction after elective and acute thoracic surgery is associated with postoperative complications. J Thorac Dis. 2020 May;12(5):2088-2095. doi: 10.21037/jtd-19-3345b.

    PMID: 32642112BACKGROUND
  • Hailu S, Shiferaw A, Regasa T, Getahun YA, Mossie A, Besha A. Incidence of Postoperative Sore Throat and Associated Factors Among Pediatric Patients Undergoing Surgery Under General Anesthesia at Hawassa University Comprehensive Specialized Hospital, a Prospective Cohort Study. Int J Gen Med. 2023 Feb 18;16:589-598. doi: 10.2147/IJGM.S397519. eCollection 2023.

    PMID: 36845340BACKGROUND
  • Thomas D, Bejoy R, Zabrin N, Beevi S. Preoperative ketamine nebulization attenuates the incidence and severity of postoperative sore throat: A randomized controlled clinical trial. Saudi J Anaesth. 2018 Jul-Sep;12(3):440-445. doi: 10.4103/sja.SJA_47_18.

    PMID: 30100844BACKGROUND

MeSH Terms

Interventions

Ketamine

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Central Study Contacts

Doaa A Abdellatif, resident

CONTACT

fawzy A Badawy, assistant professor

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Resident-anesthesia,ICU and pain manegment department-sohag hospital university

Study Record Dates

First Submitted

July 27, 2023

First Posted

August 3, 2023

Study Start

August 1, 2023

Primary Completion

January 1, 2024

Study Completion

January 1, 2024

Last Updated

August 3, 2023

Record last verified: 2023-07